Comparative study between anaesthetic drugs combination of Ketamine plus Etomidate and Ketamine plus Dexmedetomidine in Endoscopies

Comparative Study between Ketamine plus Dexmedetomidine and Ketamine plus Etomidate in Gastrointestinal Scopies - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/066829

Enrollment

108

Registered

2024-05-06

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Gastrointestinal Scopies: To see the analgesic and sedative effects of Ketamine plus Etomidate and Ketamine plus Dexmedetomidine from the commencement of procedure till the end of proce

Eligibility

Inclusion criteria

Inclusion criteria: Patient undergoing endoscopic procedures under anesthesia; American Society of Anesthesiologist Physical Status Grade I-IV

Exclusion criteria

Exclusion criteria: Patient with known allergy to drug to be injected, uncontrolled hypertension, pregnancy, Diabetic patient with HbA1c more than 10, high cardiac risk

Design outcomes

Primary

Measure	Time frame
Analgesic and sedative use of combination of Ketamine plus Etomidate and Ketamine plus Dexmedetomidine in Upper GI ScopiesTimepoint: At the time of commencement of procedure then at every 5 minutes till 45 minutes or till the patient recovers from the anaesthesia whichever is longer	—

Secondary

Measure	Time frame
Onset of sedation;Effect on hemodynamics;Any episode of Desaturation;Post procedure recovery timeTimepoint: At the time of commencement of procedure then at every 5 minutes till the patient recovers from the anaesthesia	—

Countries

India

Contacts

Public ContactVinit Pathak

Pramukhswami Medical College

mp23192@gmail.com9662520703

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026